AI can support the doctor but never replace him. Let’s see what possibilities are offered
THE’artificial intelligence it has now become part of our lives. It is increasingly used in various fields: there are those who use it to rearrange notes, those to rework texts and those to prepare reports in their work sector. Even in medical field can be used but it is important that professionals do this, exploiting the machine for its assistance and support functions, and not patients who should avoid resorting to AI to seek diagnoses.
Tumors and artificial intelligence: possible uses
—
Ian Tannockprofessor at the University of Toronto in Canada, during a recent conference in Milan dedicated to the topic ofuse of Artificial Intelligence in the medical field underlined how this tool can help especially in the oncology field, in the treatment and prevention of tumors. In fact it allows the identification of new molecular targets or new drugshelps in the evaluation of imaging tests such as mammograms. But you also need to be careful when using it for diagnosis because he may struggle more especially in complex and uncommon cases, on which he has little information. The important thing is therefore that the diagnosis and therapy process remains in the hands of a doctor which can use AI as support.
Possible uses
—
Artificial intelligence can be helpful also in research, supporting studies on new drugs, increasingly targeted for each individual patient. It was presented at the Milanese conference the widespread institution a collaboration network between various European research centers to bring their respective discoveries more quickly and expand studies which are increasingly advancing also thanks to the use of artificial intelligence. Through technological developments, two new sectors of diagnostic imaging have been introduced, the radiomics and computational pathologywhich allow us to improve the ability to stratify the risk of patients and the diagnosis of solid tumors. These innovations, before arriving at clinical use, must be validated more clearly, on the contrary the use of the evaluation of circulating tumor DNA is already used for the treatment strategies of some tumors.
© ALL RIGHTS RESERVED